Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice

Cabezas, Joaquín; Londoño, M.C.; Llerena, S.; Muñoz, R.; Baliellas, Carme; Buti, M.; Pascasio, J.M.; Sáez-Royuela, F.; García-Samaniego, J.; Vega, J. de la; Sánchez-Pobre, P.; Álvarez-Navascues, C.; Carrión, J.A.; Gea, F.; Morillas, R.M.; Fernández-Bermejo, M.; Castro-Iglesias, Ángeles; Rivero, M.; Fernández, J.R.; Berenguer, M.; Moreno, J.J.; Rincón, D.; Calleja-Panero, José Luis; Crespo, J.

View/Open

Cabezas_Efficacy.pdf (138.7Kb)

Use this link to cite

http://hdl.handle.net/2183/21654

Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España

Collections

Investigación (FCS) [1293]

Metadata

Show full item record

Title

Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice

Date

2016

Citation

Cabezas J, Londoño MC, Llerena S, et al. Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice. En: International Liver Congress; 2017 Apr 19-23; Amsterdam, The Netherlands. Amsterdam: Elsevier; 2016. p, S779 (J Hepatol. 2016; 64 Suppl 2)